Anatomy of A Bottom: Do Not Argue With Sellers – Celebrate With Buyers

So often I see “value investors” who equate the conviction of their position and alacrity of their analysis for being able to pick a bottom in a hapless stock. If the bottom fails, sometimes these investors will continue accumulating stock with each buy delivering the welcome opportunity to lower their cost basis. Meanwhile, losses keep … Read more

T2108 Update (October 21, 2015) – A Stock Market Close Enough to Overbought?

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

Hillary Clinton Takes Down the iShares Nasdaq Biotechnology: Buy the News?

The shot was heard around the world of biotech: Price gouging like this in the specialty drug market is outrageous. Tomorrow I'll lay out a plan to take it on. -H — Hillary Clinton (@HillaryClinton) September 21, 2015 The reaction was immediate and sharp for iShares Nasdaq Biotechnology (IBB) as it lost 4.6% on … Read more